Skip to content

Dieulafoy's lesion

Written and medically reviewed by Bahir Hadi, specialist in surgery, PhD

Published: 20 November 2026

Profile, experience and publications

Dieulafoy's Lesion: A Small Vessel, a Major Bleed

Dieulafoy's lesion is an unusually large artery located just beneath the mucous membrane of the stomach or other parts of the gastrointestinal tract. Instead of branching into smaller vessels as it normally would, the artery keeps its full diameter right up to the mucosal surface. When the overlying mucous membrane is damaged, this can lead to severe, often recurrent bleeding from an area that otherwise looks completely normal.

The lesion was first described by the French surgeon Paul Georges Dieulafoy in 1898. International reviews estimate that it accounts for around 1-2 percent of acute gastrointestinal bleeding [1], while the Danish clinical handbook (Lægehåndbogen) gives 1-5 percent in adults [3]. It is thought to be under-recognised rather than truly rare, and it is a classic cause of unexplained gastrointestinal bleeding.

What are the symptoms?

Dieulafoy's lesion causes no symptoms until it starts to bleed. The bleeding is typically:

  • Sudden and heavy
  • Accompanied by bloody vomiting (haematemesis) or black, tarry stools (melaena), often both
  • Without prior pain or dyspepsia
  • Often recurrent, as the bleeding can stop spontaneously and restart later

In people with significant bleeding, signs of circulatory compromise may be seen, including pallor, dizziness, palpitations and fainting.

In rarer cases the lesion is located in the small intestine, colon or rectum and causes fresh or dark rectal bleeding without a clear source at gastroscopy or colonoscopy.

Where is it located?

  • The stomach is the most common site. Of the lesions in the stomach, the great majority lie in the upper part, within about 6 cm of the junction between the oesophagus and the stomach [1,3]
  • Roughly one third are found outside the stomach, most often in the duodenum and next most often in the colon [1]
  • More rarely in the rectum and the oesophagus

The lesion is described mainly in adults, more often in men and in people with other illnesses [3]. The distribution varies between case series, and the figures cannot be transferred directly to an individual.

Why does it occur?

The cause is not known with certainty. There is a good deal to suggest that the vascular anomaly is congenital, not least because the lesion has been described in newborns, but this is a well-founded assumption rather than an established fact [1,3]. What triggers the actual bleed is often unclear. Factors that form part of the doctor's assessment include:

  • Blood-thinning medication and NSAIDs (anti-inflammatory painkillers such as ibuprofen), which increase bleeding risk in general. Lægehåndbogen notes a higher frequency after long-term NSAID use [3]
  • Mechanical wear on the mucous membrane, for example from vomiting
  • Local mucosal damage

Bleeding occurs when the thin mucous membrane over the large vessel breaks down, leaving the vessel exposed so that it ruptures.

How is it diagnosed?

Diagnosis can be difficult because the lesion is small (typically 2-5 mm) and the surrounding mucous membrane looks normal.

  • Gastroscopy is the first investigation and at the same time the treatment option in acute bleeding. The lesion is often found at the first examination, but it can be missed, not least because blood covers the mucosa or because the bleeding has stopped by the time of the examination. In a review, the diagnosis was made at the first gastroscopy in up to 70 percent, and a small group needed three or more examinations [1]. Classically a small, pulsating bleed or a visible vessel stump without a surrounding ulcer is seen.
  • Repeat gastroscopy may therefore be needed if the first examination is negative and the bleeding continues or returns [3].
  • CT angiography is useful for active bleeding that cannot be localised endoscopically.
  • Mesenteric angiography can both diagnose and treat via catheter embolisation.
  • Capsule endoscopy and balloon enteroscopy for suspected small bowel lesions.
  • Endoscopic ultrasound can in selected cases help visualise the vessel beneath the mucosa and confirm that blood flow has stopped after treatment [1].

Some patients are only diagnosed after more than one bleeding episode.

Treatment

The first choice is endoscopic treatment. It succeeds in most cases; Lægehåndbogen gives a success rate of 90-95 percent, and international reviews report above 90 percent [1,3]. The European Society of Gastrointestinal Endoscopy (ESGE) recommends thermal therapy, mechanical therapy (haemoclips or band ligation) or combination therapy, where injection of dilute adrenaline is combined with thermal or mechanical therapy, for Dieulafoy's lesion [5]. The later ESGE update from 2021 deals with bleeding peptic ulcers and refers back to the 2015 recommendations for other bleeding sources [6].

  • Haemoclips are small metal clips that close the vessel mechanically. Lægehåndbogen considers them the most suitable option [3]
  • Band ligation is an option, for instance where the stomach wall is thin [3]
  • Thermal coagulation with argon plasma or a heater probe
  • Injection of dilute adrenaline constricts the vessel and reduces the bleeding temporarily so that the lesion can be seen and treated. Adrenaline is used as an adjunct and is not a lasting treatment on its own [5]

Several techniques are often combined to secure lasting haemostasis. Rebleeding after treatment is seen in up to 20 percent, and most of these can be treated endoscopically again [3].

If endoscopic treatment fails, ESGE recommends embolisation through a catheter in the artery (transarterial embolisation) or surgery [5]:

  • Transarterial embolisation is performed by an interventional radiologist. The benefit is judged case by case
  • Surgery, typically wedge resection of the bleeding area. Reserved for patients where the other techniques cannot stop the bleeding

After successful treatment there is usually no need for a routine follow-up gastroscopy. Haemoglobin is checked by your GP, and how closely you are otherwise followed depends on the course, other illnesses and your overall medication [3].

Prognosis

Mortality has fallen markedly since endoscopic treatment became standard. One review describes a fall from around 80 percent in older series to below 10 percent in more recent ones [1]. The figures come from small series with different patient groups and periods and cannot be compared directly. Most people who have the lesion treated have a good long-term prognosis, and for most the bleeding does not return [4].

When should you seek medical attention?

Call 112 for:

  • Heavy vomiting of blood
  • A sudden large amount of red blood from the rectum
  • Fainting, rapid pulse, cold clammy skin or reduced consciousness together with abdominal symptoms

Contact the acute medical helpline (1813 in the Capital Region of Denmark, otherwise your local out-of-hours doctor) straight away and ask for urgent hospital assessment for black, tarry stools or smaller amounts of blood in vomit when you are otherwise stable.

Contact your GP for unexplained iron deficiency anaemia, especially if previous gastroscopies and colonoscopies have not identified a source.

Frequently Asked Questions

Is Dieulafoy's lesion hereditary? No familial clustering has been described. The vascular anomaly is probably congenital, but the cause is not fully understood.

Can it disappear on its own? No. The vessel remains. Bleeding may stop temporarily, but the risk of re-bleeding persists until the lesion is treated.

Why can it be hard to find? It is small, the bleeding has often stopped by the time of the examination, and the surrounding mucous membrane is normal. Experienced endoscopists therefore look specifically along the upper part of the stomach in patients with unexplained bleeding.

Will I get it again after endoscopic treatment? Some people rebleed after technically successful treatment, in published series up to one in five. Most of those who relapse can be treated endoscopically again.

Should I stop anticoagulant medication? This must be assessed individually. Stopping completely can increase the risk of blood clots, so the decision is made together with the doctors who prescribed the medication and the department that treated the bleed. Long-term NSAID use is discouraged [3].

About the figures on this page: incidence, complication, recurrence and survival figures for rare conditions come from series at specialist centres with relatively few patients, often across different time periods and using different definitions. The figures therefore vary between series and cannot be transferred directly to the individual patient.


References

  1. Baxter M, Aly EH. Dieulafoy's lesion: current trends in diagnosis and management. Ann R Coll Surg Engl. 2010;92(7):548-554. PubMed
  2. Lee YT, Walmsley RS, Leong RW, Sung JJ. Dieulafoy's lesion. Gastrointest Endosc. 2003;58(2):236-243. PubMed
  3. Sundhed.dk, Lægehåndbogen (Danish clinical handbook). Dieulafoy læsion. Updated 12 October 2023. In Danish.
  4. Sundhed.dk, Patienthåndbogen (Danish patient handbook). Mavetarmblødning, Dieulafoy læsion. Updated 12 October 2023. In Danish.
  5. Gralnek IM, Dumonceau JM, Kuipers EJ, et al. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2015;47(10):a1-a46. PubMed
  6. Gralnek IM, Stanley AJ, Morris AJ, et al. Endoscopic diagnosis and management of nonvariceal upper gastrointestinal hemorrhage (NVUGIH): ESGE Guideline, Update 2021. Endoscopy. 2021;53(3):300-332. PubMed

This article provides general information and does not replace a medical consultation. Contact your GP if you experience symptoms.

Download article as PDF (in Danish)

More on this topic at Kirurgen.dk

Category: Rare and lesser-known gastrointestinal diseases

Related

Share this page